Outcome and Long-Term Follow-Up of a Phenylketonuria Patient After Prosthetic Treatment: a Case Report

Anahtar Kelimeler:

-

Keywords:

Scriver CR, Beaudet AL, Sly WS,Valle D. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw Hill. 1667–1724.
Przyrembel H, Bremer HJ. Nutrition, physical growth, and bone density in treated phenylketonuria. Eur J Pediatr 2000;159: 129– 135.
Gassió R, Artuch R, Vilaseca MA, Fusté E, Boix C, Sans A, Campistol J. Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population. Dev Med Child Neurol 2005;47:443-448.
Roberts JF, Sheriff M. the fate and survival of amalgam and preformed restorations placed in specialist paediatric practice. Br Dent J 1990; 169:237-244.
Cleary M, Walter JH. Assessment of adult phenylketonuria. Ann Clin Biochem 2001 ;38:450-458.
Arnold GL, Vladutiu CJ, Kirby RS, Blakely EM, Deluca JM. Protein insufficiency and linear growth restriction in phenylketonuria. J Pediatr 2002;1412:243-246.
Cleary MA, Francis DE, Kilpatrick NM. Oral health implications in children with inborn errors of intermediary metabolism. Int J Paediatr Dent 1997;3:133-141.
Kilpatrick NM. Durability of restorations in primary molars. J Dent 1993;21:67-73.